Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Zepbound Outperforms CagriSema in Head to Head Phase III Obesity Trial CagriTirz (Cagrilintide + Tirz) >99% Purity CagriSema vs. Tirzepatide: Which One MELTS Fat Faster? Dr. Dan Obesity Expert